Tagged Articles

sudden death 40 articles

ADHD drug Strattera could be dangerous for patients with serious heart problems

The attention deficit hyperactivity disorder (ADHD) medication Strattera (atomoxetine hydrochloride) has an updated safety label that warns that patients with severe cardiac or vascular disorders should not take the medication. The drug can cause increases in blood pressure or heart rate that could be deadly in patients with heart problems, especially those that worsen in the event of accelerated blood pressure or heart rate. The newly updated warnings and contraindications entry on Strattera’s safety label follow a previous warning from July 2012 in which researchers observed that in adult clinical trials some patients experienced elevated blood pressure and heart rates that could ... Read More

Blood thinner Pradaxa may increase risk of flu, other viral infections

Pradaxa

The blood thinner Pradaxa may increase the risk and severity of certain viral infections including the flu and myocarditis, an infection that attacks the heart and causes sudden death, a new study suggests. Pradaxa, also known as dabigatran etexilate, was approved by the Food and Drug Administration (FDA) in 2010 to prevent strokes in patients with a type of heart rhythm abnormality known as atrial fibrillation. The drug works by inhibiting thrombin, the body’s central coagulation activator. This process, however, disturbs the protease cascade of molecular events that normally occur in coagulation, which can reduce the innate immune response to ... Read More

The events leading up to the sudden death warning with GranuFlo dialysis product

What occurred within Fresenius Medical Care (FMC), the world’s largest provider of dialysis products and services? RenalWEB sought to find the answer to that question in the second part of a two-part series looking into the high number of cardiovascular-related deaths in dialysis patients allegedly tied to GranuFlo, a product made by Fresenius and used during hemodialysis treatments. The first story in the series explained the problem. GranuFlo, a dry acid concentrate, contains an ingredient that converts to bicarbonate in the body. Elevated levels of bicarbonate have been linked to cardiovascular events, including sudden cardiac death. GranuFlo contains more of ... Read More

Native Americans more likely to need dialysis

Native Americans make up just 1.5 percent of the U.S. population, but they have one of the highest rates of end-stage renal disease. Patients with end-stage renal disease need dialysis or a kidney transplant in order to survive. Dialysis is the artificial process of getting rid of waste and unwanted water from the blood. This process is done naturally by the kidneys, but people with damaged or failed kidneys often need dialysis to regulate body levels of water and minerals, and to remove waste. Without dialysis, the amount of waste products in the blood would increase and eventually reach levels ... Read More

Dialysis giant Fresenius appoints new US CEO amid controversy surrounding GranuFlo

The Supervisory Board of German-based Fresenius Medical Care, the world’s largest provider of dialysis products and services, has appointed Ronald Kuerbitz as Chief Executive of its North American unit. Kuerbitz will succeed Rice Powell, the current CEO of the U.S. unit. Powell will assume the role of Fresenius Medical Care’s CEO and Chairman of the Management Board. As head of the U.S. unit for Fresenius, Kuerbitz will be forced to address a major red flag that came to light in March. That is when the Food and Drug Administration (FDA) received an anonymous copy of an internal memo the company ... Read More

Dialysis patients who suffered sudden cardiac arrest may have case against drug manufacturer

Attorneys at Beasley Allen Law Firm are investigating cases of sudden cardiac death associated in dialysis patients after the Food and Drug Administration (FDA) announced it is investigating Fresenius Medical Care, the nation’s largest operator of dialysis centers and producer of dialysis drugs, for failing to warn patients that use of some of its products could be deadly. On November 4, 2011, German-based Fresenius sent an internal memo to doctors in its dialysis clinics warning that the risk of heart attack was significantly higher in patients who were given GranuFlo. The company failed to warn health care professionals at other clinics ... Read More

FDA investigates makers of dialysis treatment linked to hundreds of sudden deaths

The nation’s largest operator of dialysis centers is under investigation by the Food and Drug Administration (FDA) for failing to warn patients that use of one of their products could be deadly. Fresenius Medical Care treats more than 130,000 of the estimated 400,000 Americans who receive dialysis. The company also is the leading supplier of dialysis machines and disposable products to other dialysis clinics across the country. Last November, the company’s medical office sent an internal memo to doctors at its clinics warning that improper use of one of its products could be the cause of a stark increase in ... Read More

FDA puts stronger blood clot warnings on Yaz, Yasmin birth control pills

Yaz and other newer birth control pills that contain the hormone drospirenone will get stronger warnings on their labels warning users that the drugs may be more likely than older oral contraceptives to cause blood clots, the Food and Drug Administration (FDA) announced. The new labeling will apply to Yaz, Yasmin, Beyaz, and Safyral, which are all made by Bayer. The pills are among the top selling oral contraceptives in the United States. They were marketed not only as a drug to prevent pregnancy, but also as a medication to help clear up acne and ease symptoms of premenstrual disorders. ... Read More

FDA says ADHD meds do not appear to cause heart problems

Medications to treat attention deficit-hyperactivity disorder, or ADHD, do not appear to raise the risk of heart attacks, stroke or sudden cardiac death, according to an announcement by the Food and Drug Administration (FDA). The drugs were under review by the FDA after a study suggested the drugs might contribute to serious heart problems in children who used them. More than 5 million children in the United States have been diagnosed with ADHD. Each year, about 2.7 million prescriptions are written to treat the condition, which include drugs such as Ritalin, Adderall, Concerta and Strattera. Reports of heart attacks and ... Read More

Are birth control pills for acne treatment a good idea?

The benefits of using birth control pills outweigh the risks, according to a Style Bistro story, which supports the use of oral contraceptives for the treatment of acne. There are three birth control pills that are FDA-approved for such use – Ortho Tri-Cyclen, Estrostep, and Yaz. The latter of these is one of the nation’s most prescribed birth control pills. It is also under a new safety review by the FDA based on data that links use of the pills to serious and life threatening health risks. The story lauded contraceptives for their preventative benefits: “Women on birth control see ... Read More